Why the study?
Comprehensive treatment strategies improve long-term outcomes in PAH even in mildly symptomatic patients, making it important to justify each case of monotherapy at expert centres.
A considerable number of PAH patients remain on monotherapy at expert centers, which should be justified on a case-by-case basis given the benefits of comprehensive treatment strategies.
Answers are grounded in this paper and cite their sources.
Supports individualized monotherapy decisions in PAH; leaves open need for prospective data on outcomes.
A considerable number of PAH patients are on monotherapy at large PH expert centres, characterized by specific reasons that justify this kind of treatment. Nevertheless, as comprehensive treatment strategies have shown improved long-term outcomes even in mildly symptomatic patients, each case of monotherapy should be justified.
No takes yet. Share an insight, caveat, or question.
Wißmüller et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: